|
AU7284096A
|
|
Heterocyclically-substituted 1-indole carboxamides as cyclo-oxygenase-2 inhibitors
|
|
EP0658559A1
|
|
Thienothiazin derivatives, process for their preparation and their use as 5-dipoxygenase and cyclooxygenase inhibitors
|
|
HRP940821A2
|
|
Process for the preparation of new thieno-(3',4',-4,5)imidazo (2,1-b)-thiazole derivatives
|
|
ATA102694A
|
|
Novel N-heterocyclic thienothiazinecarboxamides, process for their preparation and their use
|
|
ATA253193A
|
|
Novel aryl-substituted thienothiazine derivatives, process for their preparation and their use
|
|
ATA253093A
|
|
Novel N-heterocyclic thienothiazinecarboxamides, process for their preparation and their use
|
|
ATA246193A
|
|
New thienothiazine derivatives, a method for their production and their use
|
|
LV5499A3
|
|
Adaptation of 2-thienyloxyethyl derivatives or their pharmaceutically acceptable islands
|
|
LV5506A3
|
|
Saturation of isoxazole derivatives
|
|
LV5520A3
|
|
Saturation of 1,1-dioxo-6-chloro-4-oxo-2-methyl-N- (2-pyridyl) -2H-thieno-Ú2,3-eneazine-3-carboxylic amide ester enol ester
|
|
LV5521A3
|
|
Saturation of 5-halo-thiazothiazol-3 (2H) -one-1,1-dioxide derivatives
|
|
LV5507A3
|
|
Saturation of 4,5-dihydroxazole derivatives
|
|
LV5513A3
|
|
Saturation of 2- (2-thienyl) imidazo (4,5-c) pyridine derivatives or pharmaceutically acceptable derivatives thereof
|
|
LV5522A3
|
|
Saturation of thieno- (3 ', 4',: 4,5) -imidazo- (2,1-b) -thiazole derivatives
|
|
LTIP598A
|
|
Novel acylales of imidazol-5-carboxylic acid derivatives, process for their preparation and use thereof
|
|
HRP920819A2
|
|
New tetrazole derivatives, process for the preparation thereof and their
|
|
ATA136092A
|
|
New thienothiazine derivatives, method for the production thereof and their use
|
|
IE914501A1
|
|
New tetrazole derivatives, process for their preparation and¹their use
|
|
ATA198791A
|
|
New imidazole derivatives, method for their production and their use
|
|
EG18989A
|
|
Process for the preparation of novel thienopyran derivatives
|
